Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 06, 2016
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study.
Journal: The Lancet. Oncology
Published: October 13, 2012
Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 21, 2011
Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial.
Journal: Cancer
Published: October 03, 2011
Showing 1-4 of 4
Last Updated: 09/26/2026